Capital International Inc. CA grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 16.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 217,019 shares of the healthcare conglomerate’s stock after buying an additional 31,366 shares during the quarter. UnitedHealth Group makes up 1.3% of Capital International Inc. CA’s portfolio, making the stock its 14th largest position. Capital International Inc. CA’s holdings in UnitedHealth Group were worth $109,781,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $25,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at $28,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group during the fourth quarter worth about $30,000. Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group in the fourth quarter worth about $30,000. Finally, Promus Capital LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth approximately $32,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
Analyst Ratings Changes
A number of research firms have commented on UNH. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Barclays dropped their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Truist Financial raised their target price on shares of UnitedHealth Group from $610.00 to $660.00 and gave the stock a “buy” rating in a report on Friday, April 11th. Finally, Piper Sandler reduced their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Twenty-one research analysts have rated the stock with a buy rating and three have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $632.85.
UnitedHealth Group Trading Down 22.0 %
NYSE UNH opened at $456.10 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $438.50 and a 12 month high of $630.73. The business’s 50-day moving average price is $512.95 and its two-hundred day moving average price is $540.65. The firm has a market capitalization of $417.20 billion, a PE ratio of 29.43, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.
UnitedHealth Group (NYSE:UNH – Get Free Report) last announced its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the prior year, the business earned $6.91 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.84%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- What Are Dividend Contenders? Investing in Dividend Contenders
- AppLovin: Can Record Profits Overcome Market Skepticism?
- 3 Grocery Stocks That Are Proving They Are Still Essential
- MarketBeat Week in Review – 04/14 – 04/18
- 3 Stocks to Consider Buying in October
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.